Pregled bibliografske jedinice broj: 1170140
Our experience in treating hereditary hemochromatosis: Erythrocytapheresis vs phlebotomy
Our experience in treating hereditary hemochromatosis: Erythrocytapheresis vs phlebotomy // 23rd Regional Congres of the International Society of Blood Transfusion
Amsterdam, Nizozemska, 2013. str. 259-259 (poster, podatak o recenziji nije dostupan, sažetak, ostalo)
CROSBI ID: 1170140 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Our experience in treating hereditary
hemochromatosis: Erythrocytapheresis vs phlebotomy
Autori
Lukić, Marija ; Bojanić, Ines ; Mazić, Sanja ; Baričević, Marijana ; Gugić, DM ; Matić, I ; Golubić Ćepulić, Branka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Skup
23rd Regional Congres of the International Society of Blood Transfusion
Mjesto i datum
Amsterdam, Nizozemska, 2.-5.6
Vrsta sudjelovanja
Poster
Vrsta recenzije
Podatak o recenziji nije dostupan
Ključne riječi
hemochromatosis, erythrocytapheresis, phlebotomy
Sažetak
Ackground:Therapeutic phlebotomy (TP), the standard method of treating heredi-tary hemochromatosis (HH) is being partially replaced by erythrocytapheresis (EF)since the introduction of cell separator.Aim:The aim was to retrospectively compare the effectiveness of TP and EF inpatients with HH.Methods: In the period of 4 years (2007–2011.), 29 patients withHH were treated in the Clinical Hospital Centre Zagreb. Twelve patients (10 M, 2 F)were treated with EF and 17 patients (13 M and 4 F) with TP. Therapies wereconducted until ferritin was reduced to<50 ng/l. The hemoglobin and haematocritelevels were checked before each procedure while ferritin was controlled every3 months. EF was conducted by cell separator Haemonetics MCS+with salinevolume replacement.Results:In the TP group 153 venous punctures were made, median 5 (range 1– 25).Patients were treated with a TP for a period of 2–51 months (median 20). TP proce-dure lasted 15 min. (10–30) and 450 ml of whole blood (range 200–500) was col-lected. Before the first TP median ferritin was 1064 ng/ml (range 360–5955) and thefinal was 421 mg/l (range 82–5053). In the EF group 120 EF were done, median 8(range 4–24). Treatment with EF lasted in range of 4–55 months (median 36). EFlasted 35 min (range 26–54), 1075 ml of blood was processed (range 744–1340) and
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Klinički bolnički centar Zagreb
Profili:
Branka Golubić Ćepulić
(autor)
Igor Matić
(autor)
Ines Bojanić
(autor)
Sanja Mazić
(autor)
Marija Lukić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE